Richman DD - Search Results

1

The prevalence of antiretroviral drug resistance in the United States.

Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. Richman DD, et al. AIDS. 2004 Jul 2;18(10):1393-401. doi: 10.1097/01.aids.0000131310.52526.c7. AIDS. 2004. PMID: 15199315

2

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.

Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman DD; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: richman dd. AIDS. 2005 Feb 18;19(3):295-302. AIDS. 2005. PMID: 15718840 Clinical Trial.

3

Antiretroviral-drug resistance among patients recently infected with HIV.

Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. Little SJ, et al. Among authors: richman dd. N Engl J Med. 2002 Aug 8;347(6):385-94. doi: 10.1056/NEJMoa013552. N Engl J Med. 2002. PMID: 12167680 Free article.

4

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, Richman DD, Little SJ. Leigh Brown AJ, et al. Among authors: richman dd. J Infect Dis. 2003 Feb 15;187(4):683-6. doi: 10.1086/367989. Epub 2003 Jan 29. J Infect Dis. 2003. PMID: 12599087

5

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.

Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team. Kemper CA, et al. AIDS. 2001 Mar 30;15(5):609-15. doi: 10.1097/00002030-200103300-00010. AIDS. 2001. PMID: 11316998

6

Rapid evolution of the neutralizing antibody response to HIV type 1 infection.

Richman DD, Wrin T, Little SJ, Petropoulos CJ. Richman DD, et al. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9. doi: 10.1073/pnas.0630530100. Epub 2003 Mar 18. Proc Natl Acad Sci U S A. 2003. PMID: 12644702 Free PMC article.

7

HIV drug resistance acquired through superinfection.

Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ. Smith DM, et al. Among authors: richman dd. AIDS. 2005 Aug 12;19(12):1251-6. doi: 10.1097/01.aids.0000180095.12276.ac. AIDS. 2005. PMID: 16052079

8

HIV evolution and escape.

Richman DD, Little SJ, Smith DM, Wrin T, Petropoulos C, Wong JK. Richman DD, et al. Trans Am Clin Climatol Assoc. 2004;115:289-303. Trans Am Clin Climatol Assoc. 2004. PMID: 17060974 Free PMC article. Review.

9

Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.

Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM. Liu L, et al. Among authors: richman dd. AIDS. 2008 Apr 23;22(7):835-9. doi: 10.1097/QAD.0b013e3282f5ff71. AIDS. 2008. PMID: 18427201 Free PMC article.

10

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Little SJ, et al. Among authors: richman dd. JAMA. 1999 Sep 22-29;282(12):1142-9. doi: 10.1001/jama.282.12.1142. JAMA. 1999. PMID: 10501117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters